All Articles

The firm is now recruiting for a Phase 1 trial of HWK-007 and has submitted an IND for HWK-016, targeting tough lung, ovarian, and endometrial cancers.

While humanoid robots grab headlines, Linkerbot quietly captured 80% of the dexterous hand market with revolutionary cost and production scale.

The cybersecurity firm renewed its multi-million dollar GRC contract with a Fortune 100 client, signaling deep trust and validating its market strategy.

As the AI arms race heats up, Lambda brings in veteran operator Leonard Speiser to lead its $1.5B+ expansion and build the future of AI supercomputing.

Frontier Airlines appoints decade-long veteran James Dempsey as its new CEO and raises its Q4 earnings outlook, signaling operational resilience.

The LA Rams and energy firm CRC mark one year of a partnership to offset team emissions, but does this innovative, local-first model truly change the game?

The deal integrates specialized AI and therapist-led platforms to boost mental health access for remote communities and spearhead global expansion.

The hospitality tech giant is leveraging its platform with a new AI assistant for retailers, aiming to automate inventory, boost margins, and challenge market leaders.

Vuzix wins a CES 2026 Innovation Award for its Ultralite Pro, smart glasses so discreet they look ordinary but pack powerful AI for the enterprise.

With pivotal data for its sickle cell drug and a new myelofibrosis program, Cellarity's AI-driven 'Cell State-Correcting' platform faces a crucial test.

With multiple clinical trials advancing and a savvy global expansion, RESTEM is poised to challenge the treatment paradigm for autoimmune disorders.

Safi Biotherapeutics and ARMI | BioFabUSA achieve a critical step toward mass-producing red blood cells, offering hope for patients and military readiness.

At CES 2026, Hitachi unveiled major AI alliances with NVIDIA and Google, betting its HMAX platform can embed intelligence into the world's core systems.

The biotech firm launches an early access program for its novel platform, starting with a tau assay that could revolutionize Alzheimer's research.

A new partnership leverages in vivo screening to find novel obesity targets, aiming to revolutionize a market projected to exceed $100 billion.

The National Retail Federation partners with Insider One, using advanced AI to personalize its massive 2026 trade show for 40,000 attendees.

Targa Exploration grows its El Zanjon project by 66% in a key gold district, signaling a major push to uncover a new discovery in Santa Cruz.

Cizzle Brands' $83.75M acquisition of Flow Water's manufacturing arm is a strategic masterstroke, creating a vertically integrated beverage powerhouse.

With a major cash infusion and key pipeline milestones, Xilio Therapeutics validates its tumor-activated approach to fighting cancer and extends its runway to 2027.

Positive early human safety data for its lead drug and new candidates for Rett syndrome and MASH signal a pivotal year for ProQR's Axiomer technology.